TherapeuticsMD shares jump 20% on menopause drug study results
TherapeuticsMD Inc. shares jumped in the extended session Monday after the women's drug developer said a late-stage clinical trial showed its drug candidate reduced vasomotor symptoms in women going through menopause. TherapeuticsMD shares surged 22% to $7.52 after hours on heavy volume. Vasomotor symptoms include such occurrences as night sweats, hot flashes, and flushes. The company said its drug candidate TX-001HR significantly reduced the number and severity of these symptoms in menopausal and post-menopausal women compared to those treated with a placebo.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.